Engagement — Platform Due Diligence
Code & Co. provides AI & Tech Due Diligence to Opus Origin ahead of its investment in LSI, a medtech market intelligence, media and events company and operator of the Compass AI intelligence platform.
Life Science Intelligence ("LSI"), the company behind the world's leading medtech innovation and investment summits and the Compass AI intelligence platform, has announced a strategic partnership with Opus Origin, the London-based specialist investor. Opus Origin will deploy its deep operational experience to strengthen LSI's ability to serve the global medtech and life sciences innovation and investment ecosystem. The Company will also deepen the data, research, and AI capabilities of Compass AI, its proprietary intelligence platform, while expanding its digital media and editorial coverage that keeps the global medtech ecosystem informed and connected year-round.
Scope of work
Code & Co. advised Opus Origin on AI & Tech Due Diligence through a detailed evaluation of LSI’s Compass AI platform, covering its AI strategy, technical architecture, cybersecurity, and infrastructure and hosting. The assessment examined the engineering organization, the software development lifecycle, and the product roadmap. The engagement also extended to a range of further technology areas.
About LSI
Life Science Intelligence is a leading medtech market intelligence, media and events company. LSI produces the industry's premier innovation and investment summits bringing together over 3,500 executives and investors annually across the United States, Europe and Asia, and operates Compass AI, the AI-powered intelligence platform for the private medtech markets. It was founded in 2006 and is based in Huntington Beach, California. Since 2022 alone, LSI alumni companies have completed more than 700 private financing and M&A transactions totaling nearly $15 billion, including 35 acquisitions. Scott Pantel will continue to lead LSI as CEO, working with the existing team to write the Company's next chapter. To learn more, visit lifesciencemarketresearch.com.
About Opus Origin
Opus Origin is a specialist investor with a unique blend of operational experience and value-creation expertise. The firm focuses on mixed-media business models that leverage rich, proprietary data to generate unique insights and long-term customer value. Founded on decades of experience and a long-term investment philosophy, the firm partners with founders and management teams to accelerate growth through investment in people, platforms, and product strategy, while preserving the culture and independence that make their businesses distinctive. Based in London, Opus Origin turns trusted communities into category-defining global platforms across live events, media, data and investment. In October 2026, Opus Origin announced the appointment of Desiree Hanson as President, North America, working alongside Chairman, North America, Greg Topalian, CEO, Sam Jennings, and the Opus Origin leadership team. To learn more, visit opusorigin.com.

